Meeder Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,774
Closed -$47.5K 951
2024
Q2
$47.5K Buy
+1,774
New +$47.5K ﹤0.01% 346
2022
Q4
Sell
-17
Closed -$1K 1862
2022
Q3
$1K Buy
17
+1
+6% +$59 ﹤0.01% 2021
2022
Q2
$0 Sell
16
-229
-93% ﹤0.01% 2425
2022
Q1
$8K Buy
+245
New +$8K ﹤0.01% 1646
2021
Q4
Sell
-292
Closed -$8K 2203
2021
Q3
$8K Buy
292
+33
+13% +$904 ﹤0.01% 1768
2021
Q2
$8K Sell
259
-1,660
-87% -$51.3K ﹤0.01% 1795
2021
Q1
$50K Buy
+1,919
New +$50K ﹤0.01% 1106
2020
Q4
Sell
-4,946
Closed -$102K 2206
2020
Q3
$102K Buy
+4,946
New +$102K 0.01% 777
2019
Q2
Sell
-819
Closed -$28K 2136
2019
Q1
$28K Sell
819
-61
-7% -$2.09K ﹤0.01% 990
2018
Q4
$30K Buy
880
+736
+511% +$25.1K ﹤0.01% 943
2018
Q3
$7K Sell
144
-96
-40% -$4.67K ﹤0.01% 1257
2018
Q2
$14.4K Sell
240
-952
-80% -$57K ﹤0.01% 1050
2018
Q1
$55K Sell
1,192
-1,329
-53% -$61.3K 0.01% 651
2017
Q4
$100K Buy
2,521
+249
+11% +$9.88K 0.01% 565
2017
Q3
$91K Sell
2,272
-110
-5% -$4.41K 0.01% 581
2017
Q2
$103K Buy
2,382
+2,315
+3,455% +$100K 0.01% 555
2017
Q1
$2K Buy
+67
New +$2K ﹤0.01% 1405
2016
Q3
Sell
-2,307
Closed -$47K 935
2016
Q2
$47K Sell
2,307
-23,509
-91% -$479K ﹤0.01% 732
2016
Q1
$394K Hold
25,816
0.04% 458
2015
Q4
$347K Sell
25,816
-23,351
-47% -$314K 0.03% 438
2015
Q3
$690K Buy
+49,167
New +$690K 0.07% 273